Qualicaps to Be Acquired by Mitsubishi Chemical Holdings

December 25, 2012

Qualicaps to Be Acquired by Mitsubishi Chemical Holdings


Dallas, Date: Global private equity firm The Carlyle Group (“Carlyle”) announced today that it has signed an agreement for the sale of Qualicaps, to Mitsubishi Chemical Holdings. Mitsubishi Chemical Holdings is a Japanese Holding Company mainly operates the leading Chemical and Healthcare businesses. The transaction is subject to regulatory approvals and is expected to close in March 2013.

“In partnership with Carlyle since 2005, we have been able to transform Qualicaps into a business that provides consistent, innovative high quality capsules to our pharmaceutical and health and nutrition customers alike, said Bernd Brust, Chairman and CEO of Qualicaps. “Joining with Mitsubishi Chemical Holdings, a well-established, larger multinational company will allow for further strategic expansion of our manufacturing, quality, and innovation capabilities.”

About: Mitsubishi Chemical Holdings
At the Mitsubishi Chemical Holdings Group, we serve our customers by using our chemistry-based technology platforms for the development of a wide range of technologies and products in the fields of performance products, healthcare, and industrial materials. Under the Group philosophy: “Good Chemistry for Tomorrow”, we established a new concept, KAITEKI which encompasses sustainability, health, and comfort. We aim to realize a truly sustainable state of comfort, not only for individuals but for society and the earth as a whole, through providing our technologies and products. As the Mitsubishi Chemical Holdings Group, we posted net sales of about ¥3,200 billion in fiscal year ended March 2012 and had more than 54,000 employees as of the end of the year. Further information about Mitsubishi Chemical Holdings is available on our websites: www.mitsubishichem-hd.co.jp/english/

About: Qualicaps
Qualicaps is a global company that partners primarily with pharmaceutical companies to provide empty two-piece hard capsules and pharmaceutical processing equipment. The Company is the world’s second largest provider of Hard Capsules to the global pharmaceutical industry with over 115 years of experience in the capsule business. Through its seven facilities in Europe, Japan and North America, the Company’s global production capabilities provide the capacity, consistency and reliability of supply that is demanded by the global pharmaceutical industry, bringing its clients to market faster and more reliably to improve human health. The company was founded in 1965 and currently employs 1,000 individuals around the world. www.Qualicaps.com

About The Carlyle Group
The Carlyle Group (NASDAQ: CG) is a global alternative asset manager with approximately $157 billion of assets under management in 101 funds and 64 fund of fund vehicles as of September 30, 2012. Carlyle’s purpose is to invest wisely and create value. Carlyle invests across four segments – Corporate Private Equity, Real Assets, Global Market Strategies and Fund of Funds Solutions – in Africa, Asia, Australia, Europe, the Middle East, North America and South America. Carlyle has expertise in various industries, including: aerospace, defense & government services, consumer & retail, energy, financial services, healthcare, industrial, technology & business services, telecommunications & media and transportation. The Carlyle Group employs 1,300 people in 32 offices across six continents. www.Carlyle.com


Qualicaps Co.,Ltd.
Media Contact: Akihiko Kawauchi
Phone: +81-743-57-8597